Medivation, Inc. (NASDAQ:MDVN)

CAPS Rating: 2 out of 5

A biopharmaceutical company engaged in the acquisition, research and development of promising medical technologies.

Recs

0
Player Avatar musclemilk13 (98.53) Submitted: 4/26/2010 3:24:01 PM : Outperform Start Price: $11.37 MDVN Score: +659.76

copying andrelikesMTL

Report this Post Reply

Featured Broker Partners


Advertisement